evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/geneAliases/6,gene/geneAliases/7,gene/geneAliases/8,gene/geneAliases/9,gene/geneAliases/10,gene/geneAliases/11,gene/geneAliases/12,gene/geneAliases/13,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract
17896,GENE_BACKGROUND,,"The CXCR4 gene encodes an alpha-chemokine receptor specific to a stromal-derived factor CXCL12, a molecule with potent chemotactic activity for lymphocytes. Through autocrine and paracrine interactions, the CXCR4-CXCL12 signaling axis promotes cancer cell proliferation, survival, motility and drug resistance (PMID: 20484021). Expression of CXCR4 in cancer cells has been linked to metastasis to tissues containing high levels of CXCL12, like the bone, lungs, liver and lymph nodes (PMID: 21866172, PMID: 20484021, PMID: 17891505, PMID: 11242036). The CXCR4-CXCL12 axis was also found to induce angiogenesis in several malignancies through hypoxia-induced CXCR4 expression and recruitment of endothelial progenitor cells to tumors (PMID: 15180966, PMID: 15882617, PMID: 21618540). Very few mutations in CXCR4 have been reported, but its elevated expression is a poor prognostic marker in many cancers, including breast, ovarian, melanoma and prostate cancers. A dominant germ line mutation in CXCR4 causes WHIM syndrome, an immunodeficiency disorder characterized by neutropenia (PMID: 21178277). Further, a somatic mutation in CXCR4 was recently identified in Waldenström macroglobulinemia, an indolent B-cell malignancy (PMID: 24366360). Inhibitors of the CXCL4-CXCL12 axis are in several Phase I/II clinical trials for stem cell mobilization and HIV research; these inhibitors have not yet been evaluated in the context of cancer (PMID: 24141062).",,2017-01-09,,7852,CXCR4,C-X-C motif chemokine receptor 4,False,ENST00000241393,NM_003467.2,NPYRL,CD184,NPY3R,HM89,NPYY3R,LAP-3,HSY3RR,D2S201E,LCR1,WHIMS,LESTR,FB22,WHIM,NPYR,False,15180966,"Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.",FASEB journal : official publication of the Federation of American Societies for Experimental Biology,2018-08-01T20:04:00,18,11,1240-2,Darash-Yahana M et al,,,0001-08-01,,21866172,Homeostatic chemokine receptors and organ-specific metastasis.,Nature reviews. Immunology,2018-08-25T20:11:00,11,9,597-606,Zlotnik A et al,doi: 10.1038/nri3049,,2018-08-25T06:06:00,,24141062,"The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer.",Cancer letters,2018-09-28T20:14:00,352,True,36-53,Weitzenfeld P et al,doi: 10.1016/j.canlet.2013.10.006,,0001-09-28,,21618540,The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.,The Journal of pathology,2018-07-01T20:11:00,224,3,344-54,Ping YF et al,doi: 10.1002/path.2908,,0001-07-01,,11242036,Involvement of chemokine receptors in breast cancer metastasis.,Nature,2018-03-01T20:01:00,410,6824,1950-06-01,Müller A et al,,,0001-03-01,,24366360,"The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.",Blood,2018-03-13T20:14:00,123,11,1637-46,Hunter ZR et al,doi: 10.1182/blood-2013-09-525808,,0001-03-13,,15882617,Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.,Cell,2018-05-06T20:05:00,121,3,335-48,Orimo A et al,,,0001-05-06,,20484021,CXCL12 (SDF-1)/CXCR4 pathway in cancer.,Clinical cancer research : an official journal of the American Association for Cancer Research,2018-06-01T20:10:00,16,11,2927-31,Teicher BA et al,doi: 10.1158/1078-0432.CCR-09-2329,,0001-06-01,,21178277,CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.,Disease markers,2010,29,2001-03-04,189-98,Bachelerie F,doi: 10.3233/DMA-2010-0736,,2018-03-04T20:10:00,,17891505,Organ selectivity in metastasis: regulation by chemokines and their receptors.,Clinical &amp; experimental metastasis,2008,25,4,345-56,Ben-Baruch A,,,Ben-Baruch A. Clinical &amp; experimental metastasis. 2008;25(4)345-56.,
17895,GENE_SUMMARY,,"CXCR4 encodes a chemokine receptor involved in signaling pathways related to chemotaxis, cell survival and proliferation. Mutations in CXCR4 were recently identified in B-cell malignancies and expression of this receptor has been observed in a broad spectrum of cancers, including breast, ovarian, melanoma and prostate cancers.",,2017-01-09,,7852,CXCR4,C-X-C motif chemokine receptor 4,False,ENST00000241393,NM_003467.2,NPYRL,CD184,NPY3R,HM89,NPYY3R,LAP-3,HSY3RR,D2S201E,LCR1,WHIMS,LESTR,FB22,WHIM,NPYR,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
